Time ROC curves further validated the efficacy of SOCS1 in forecasting glioma patient outcomes, showing the highest accuracy at the third year with an AUC of 64.0% in the CGGA database (Fig. 10K) and 85.2% in the TCGA database (Fig. 10L), indicating peak predictive precision at this timeline. Here, SOCS1 is linked to glioma.